查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1748750

合約研究組織市場－全球產業規模、佔有率、趨勢、機會和預測（按服務、應用、地區和競爭細分，2020-2030 年預測）

Contract Research Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球合約研究組織 (CRO) 市場價值為 521.5 億美元，預計到 2030 年將達到 681.5 億美元，複合年成長率為 4.76%。藥物開發日益複雜的過程、高成本以及嚴格的監管審查是推動市場成長的關鍵因素。製藥和生技公司面臨越來越大的壓力，需要在遵守全球監管架構的同時，加速開發進度、控制開支。為了實現這一目標，許多公司將臨床和臨床前研究職能外包給 CRO，後者提供專業知識、全球基礎設施和尖端技術。 CRO 在簡化開發工作流程、管理合規性和實現研究工作的可擴展性方面發揮關鍵作用。然而，競爭壓力、跨地區不斷變化的監管環境以及對嚴格的資料完整性和良好臨床實踐 (GCP) 合規性的需求阻礙了市場成長。儘管面臨這些挑戰，CRO 仍然是在日益全球化的製藥領域提供經濟高效的研究服務的策略合作夥伴。

市場概覽
預測期 2026-2030
2024年市場規模 521.5億美元
2030年市場規模 681.5億美元
2025-2030 年複合年成長率 4.76%
成長最快的領域 早期開發服務
最大的市場 北美洲

關鍵市場促進因素

醫療保健產業的成長

主要市場挑戰

臨床試驗成本上升

主要市場趨勢

生物相似藥和生物製劑試驗的增加

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：COVID-19 對全球合約研究組織市場的影響

第5章：全球合約研究組織市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按服務（早期開發服務、臨床研究服務、實驗室服務、諮詢服務、資料管理服務）
    • 依應用（腫瘤學、中樞神經系統、心血管、呼吸系統、傳染病、自體免疫疾病、其他）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖

第6章：北美合約研究組織市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第7章：歐洲合約研究組織市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區合約研究組織市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第9章：南美洲合約研究組織市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲合約研究組織市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 合併與收購（如有）
  • 產品發布（如有）
  • 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：全球合約研究組織市場：SWOT 分析

第 15 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 16 章：競爭格局

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen NV

第 17 章：策略建議

第18章調查會社について,免責事項

簡介目錄
Product Code: 7311

The Global Contract Research Organization Market was valued at USD 52.15 Billion in 2024 and is projected to reach USD 68.15 Billion by 2030, growing at a CAGR of 4.76%. The increasing complexity, cost, and regulatory scrutiny associated with drug development are key factors fueling the market's growth. Pharmaceutical and biotechnology companies are facing mounting pressure to accelerate development timelines and manage expenses while complying with global regulatory frameworks. To achieve this, many are outsourcing clinical and preclinical research functions to CROs, which offer specialized expertise, global infrastructure, and cutting-edge technologies. CROs play a pivotal role in streamlining development workflows, managing compliance, and enabling scalability in research efforts. However, market growth is tempered by competitive pressures, evolving regulatory landscapes across regions, and the need for stringent data integrity and Good Clinical Practice (GCP) compliance. Despite these challenges, CROs continue to be strategic partners in delivering cost-effective and efficient research services across an increasingly globalized pharmaceutical landscape.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 52.15 Billion
Market Size 2030USD 68.15 Billion
CAGR 2025-20304.76%
Fastest Growing SegmentEarly Phase Development Services
Largest MarketNorth America

Key Market Drivers

Growth in Healthcare Industry

The rapid expansion of the global healthcare industry is a major driver of the Contract Research Organization market. Rising investments in biopharmaceutical R&D, increasing focus on personalized medicine, and an expanding portfolio of therapeutic innovations are prompting pharmaceutical and medical device companies to seek external support from CROs. Countries such as Finland, Belgium, and Japan are leading with highly efficient healthcare systems, while even advanced markets like the U.S. face ongoing challenges in cost and care accessibility. With millions remaining uninsured and healthcare systems under pressure, pharmaceutical companies are leveraging CROs to improve efficiency and minimize development risks. CROs offer a range of services-spanning early-stage discovery to post-market surveillance-that help sponsors navigate complex clinical and regulatory environments. As healthcare demands rise, so does the need for efficient outsourcing solutions that CROs are well-positioned to provide.

Key Market Challenges

Rising Cost of Clinical Trials

Escalating costs associated with conducting clinical trials present a significant challenge for the CRO industry. As trial protocols become more complex, involving diverse geographies, larger patient populations, and advanced data requirements, the financial burden on sponsors and service providers increases. Additional costs stem from the integration of high-end technologies, including biomarker analysis, genomic profiling, and real-time data monitoring tools-all of which require significant investment in infrastructure and expertise. Logistical complexities associated with managing global trial sites and ensuring regulatory compliance across jurisdictions add further operational strain. For CROs, balancing cost-efficiency with quality service delivery remains a critical concern, particularly when servicing cost-sensitive clients or navigating budget constraints in emerging markets.

Key Market Trends

Rise in Biosimilars and Biologics Trials

The expanding focus on biosimilars and biologics is reshaping the global CRO landscape. The expiration of patents on high-value biologic drugs has opened opportunities for biosimilar development, especially in markets like India that offer cost-effective research ecosystems and supportive regulatory structures. India is increasingly recognized as a preferred location for biosimilar trials due to its skilled workforce and favorable clinical infrastructure. Meanwhile, the rise of complex biologics-including monoclonal antibodies, vaccines, and gene therapies-requires specialized research capabilities. CROs equipped to handle bioanalytical testing, immunogenicity evaluation, and biomarker analysis are in high demand as sponsors look for end-to-end biologics expertise. This trend reflects a broader shift toward advanced therapies and precision medicine, with CROs playing a vital role in accelerating development and navigating the regulatory complexities of modern biologics.

Key Market Players

  • GE HealthCare Technologies Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • PerkinElmer Inc.
  • Standard BioTools Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories Inc.
  • Cepheid Inc.
  • Thermo Fisher Scientific, Inc.
  • Qiagen N.V.

Report Scope

In this report, the Global Contract Research Organization Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Contract Research Organization Market, By Service:

  • Early Phase Development Services
  • Clinical Research Services
  • Laboratory Services
  • Consulting Services
  • Data Management Services

Contract Research Organization Market, By Application:

  • Oncology
  • Central Nervous System
  • Cardiovascular
  • Respiratory
  • Infectious Diseases
  • Autoimmune Disorders
  • Others

Contract Research Organization Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Contract Research Organization Market.

Available Customizations

Global Contract Research Organization Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Contract Research Organization Market

5. Global Contract Research Organization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service (Early Phase Development Services, Clinical Research Services, Laboratory Services, Consulting Services, Data Management Services)
    • 5.2.2. By Application (Oncology, Central Nervous System, Cardiovascular, Respiratory, Infectious Diseases, Autoimmune Disorders, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Contract Research Organization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Contract Research Organization Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Application
    • 6.3.2. Mexico Contract Research Organization Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Application
    • 6.3.3. Canada Contract Research Organization Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Application

7. Europe Contract Research Organization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Contract Research Organization Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Application
    • 7.3.2. Germany Contract Research Organization Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Application
    • 7.3.3. United Kingdom Contract Research Organization Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Application
    • 7.3.4. Italy Contract Research Organization Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Service
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Contract Research Organization Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Service
        • 7.3.5.2.2. By Application

8. Asia Pacific Contract Research Organization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Contract Research Organization Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Application
    • 8.3.2. India Contract Research Organization Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Application
    • 8.3.3. South Korea Contract Research Organization Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Application
    • 8.3.4. Japan Contract Research Organization Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Service
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Contract Research Organization Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Service
        • 8.3.5.2.2. By Application

9. South America Contract Research Organization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Contract Research Organization Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Contract Research Organization Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Contract Research Organization Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Application

10. Middle East and Africa Contract Research Organization Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Service
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Contract Research Organization Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Service
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Contract Research Organization Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Service
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Contract Research Organization Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Service
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Disruptions : Conflicts, Pandemics and Trade Barriers

14. Global Contract Research Organization Market: SWOT Analysis

15. Porters Five Forces Analysis

  • 15.1. Competition in the Industry
  • 15.2. Potential of New Entrants
  • 15.3. Power of Suppliers
  • 15.4. Power of Customers
  • 15.5. Threat of Substitute Products

16. Competitive Landscape

  • 16.1. GE HealthCare Technologies Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Company Snapshot
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As Reported)
    • 16.1.5. Recent Developments
    • 16.1.6. Key Personnel Details
    • 16.1.7. SWOT Analysis
  • 16.2. Abbott Laboratories
  • 16.3. Agilent Technologies, Inc.
  • 16.4. PerkinElmer Inc.
  • 16.5. Standard BioTools Inc.
  • 16.6. Illumina, Inc.
  • 16.7. Bio-Rad Laboratories Inc.
  • 16.8. Cepheid Inc.
  • 16.9. Thermo Fisher Scientific, Inc.
  • 16.10. Qiagen N.V.

17. Strategic Recommendations

18. About Us & Disclaimer